Initiatives for Lymphatic Filariasis

Activity List

• 
  Eisai was Awarded Certificate of Appreciation by the National Department of Health of Papua New Guinea for Eisai’s Support towards COVID-19

  August 30, 2021

• 
  Lymphatic Filariasis Elimination Activities in Papua New Guinea
  Eisai Donated Masks and Gloves for COVID-19 Countermeasures in Mass Drug Administration

  July 2, 2021

• 
  Activities for Lymphatic Filariasis Elimination in Kenya

  February 19, 2021

Current Distribution Status of DEC Tablets for Endemic Countries

• In November 2010, Eisai agreed to provide 2.2 billion DEC (diethylcarbamazine) tablets free of charge through WHO to lymphatic filariasis endemic countries worldwide by 2020
• In August 2013, Eisai's DEC tablets obtained prequalification from WHO, the first Neglected Tropical Disease treatment to receive prequalification in the world
• In October 2013, DEC tablet provision commenced from our Vizag plant
• In April 2017, Eisai announced that it would continue to provide DEC tablets to endemic countries that need them beyond 2020, until complete elimination is achieved

Countries where DEC tablets are supplied and countries where lymphatic filariasis (LF) is eliminated

●  Countries where distribution has commenced

Countries where LF is eliminated

LF elimination was achieved in Egypt, Kiribati, Thailand and Sri Lanka out of 28 countries, where Eisai has provided DEC tablets.

• September 1, 2020

  Lymphatic Filariasis Elimination Activities in Myanmar

• February 13, 2020

  DEC Project Managers' Efforts to Support Lymphatic Filariasis Elimination Activities

• December 11, 2018

  Eisai Ranked 8th in the Access to Medicine Index 2018